electroCore granted two new U.S. patents

electroCore has received patent issue notifications from the USPTO. The two patents were issued on December 26, 2023, and relate to electroCore’s non-invasive vagus nerve stimulation – nVNS – technology: one patent relates to systems and methods for treating medical conditions that include delivering an nVNS therapy regimen, detecting a heart rate variability of the patient, and comparing the HRV with data related to parameters of the therapy regimen. The other patent relates to a medical device that includes a signal generator for applying electrical impulses to the patient for a period of time, wherein the device is configured to deactivate upon a first occurrence of a specific number of single doses being applied to the patient or a specific time elapsing after the first dose is applied.